Evaluation of Psychological Impact of Group Therapy for Patients Who Have Been Hospitalized in Intensive Care During COVID-19 Pandemic: Exploratory Study
NCT ID: NCT04747405
Last Updated: 2023-08-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
59 participants
INTERVENTIONAL
2021-02-22
2022-12-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
For all these reasons the investigators fear that patients hospitalized in intensive care during COVID-19 pandemic develop psychological trouble with an increased risk for those who experienced COVID-19 infection. The hypothesis therapy group added to standard care might have a positive impact on psychological troubles such as anxiety, depression and post traumatic stress disorder for patients who have been hospitalized in intensive care during COVID-19 pandemic.
The investigators will compare two groups:
* group receiving standard of care
* group receiving standard of care and therapy group
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of SARS-CoV-2 Effect on Post-traumatic Stress of Patients Hospitalized in Intensive Care Unit
NCT04872049
Impact of Covid-19 Restrictive Measure on Anxiety, Depression and PTSD for Relatives of ICU Patients
NCT04430049
Neuropsychological Impact of Hospitalization on Intubated, Ventilated and Sedated ICU Patients
NCT01838798
Psychological Burden in ICU Survivors of Severe COVID-19 Pneumonia, Their Relatives and Their Healthcare Providers
NCT04341519
Targeted Group-based Psychotherapy to Address Emotional Stress in at Risk ICU Survivors
NCT05856240
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A standard
standard of care
No interventions assigned to this group
B therapy group
standard of care and therapy group
therapy group
therapy group of maximum 8 people repeated twice
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
therapy group
therapy group of maximum 8 people repeated twice
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* hospitalized at least 72h in intensive care during COVID-19 pandemic crisis
* out of intensive care for at least 2 months and maximum 6 months
* psychological evaluation done according to local practice and standard of care
* speaking french
* patient coming alone to the therapy group
* patient agree to respect confidentiality rules and demonstrating goodwill with others participants
* patient comite to respecting barriers rules against COVID-19
* affiliated to social security system
* no juridic protection engaged
Exclusion Criteria
* drug addiction
* participation to other interventional clinical trial
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Metropole Savoie
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Romain PERCOT
Role: STUDY_DIRECTOR
Cebtre Hospitalier Metropole Savoie
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CH Métropole Savoie
Chambéry, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CHMS20009
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.